Bel Air Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$1.45M Sell
21,670
-6,569
-23% -$428K 0.04% 154
2021
Q1
$1.78M Buy
+28,239
New +$1.76M 0.06% 135

Other funds holding BMY

Bel Air Investment Advisors's BMY Position: Q2 2021 in Review

Bel Air Investment Advisors reduced its Bristol-Myers Squibb (BMY) stake by 23% in Q2 2021, selling an estimated $428K and leaving 21,670 shares worth $1.45M. The position accounts for 0.04% of the portfolio, ranked #154.

Bel Air Investment Advisors first reported a position in BMY in Q1 2021 and has held it in 2 quarters since. The position peaked at $1.78M in Q1 2021. 2,370 funds tracked by Wall St. Rank hold BMY as of Q2 2021.

  • Bel Air Investment Advisors held 21,670 shares of Bristol-Myers Squibb worth $1.45M as of Q2 2021.
  • Bel Air Investment Advisors sold 6,569 Bristol-Myers Squibb shares in Q2 2021, an estimated $428K.
  • Bristol-Myers Squibb made up 0.04% of Bel Air Investment Advisors's portfolio in Q2 2021, its #154 holding.
  • Bel Air Investment Advisors first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 2 quarters since.
  • Bel Air Investment Advisors's Bristol-Myers Squibb position peaked at $1.78M in Q1 2021.
  • 2,370 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.

Based on Bel Air Investment Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.